Spahia N - Search Results

1

Inflammation, Left Ventricular Hypertrophy, and Mortality in End-stage Renal Disease.

Cafka M, Rroji M, Seferi S, Barbullushi M, Burazeri G, Spahia N, Idrizi A, Likaj E, Seiti J, Lazaj J, Goda A. Cafka M, et al. Among authors: spahia n. Iran J Kidney Dis. 2016 Jul;10(4):217-23. Iran J Kidney Dis. 2016. PMID: 27514769 Free article.

2

Influence of Residual Renal Function in Carotid Modeling as a Marker of Early Atherosclerosis in Dialysis Patients.

Rroji M, Spahia N, Seferi S, Barbullushi M, Spasovski G. Rroji M, et al. Among authors: spahia n. Ther Apher Dial. 2017 Oct;21(5):451-458. doi: 10.1111/1744-9987.12548. Epub 2017 Jul 17. Ther Apher Dial. 2017. PMID: 28714271

3

The Treatment with Mycophenolate Mofetil of Corticoresistent Nephrotic Syndrome by Idiopathic Focal Segmental Glomerulosclerosis: Analysis of Twenty Cases.

Rroji M, Spahia N, Barbullushi M, Sasdelli M. Rroji M, et al. Among authors: spahia n. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019 Dec 1;40(3):135-137. doi: 10.2478/prilozi-2020-0013. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019. PMID: 32109210 Free article. No abstract available.

4

Subclinical Hypothyroidism, Kidney, and Heart from Normal to Uremic Milieu.

Spahia N, Rroji M, Barbullushi M, Spasovski G. Spahia N, et al. Metab Syndr Relat Disord. 2023 Oct;21(8):415-425. doi: 10.1089/met.2023.0057. Epub 2023 Jul 11. Metab Syndr Relat Disord. 2023. PMID: 37433213 Review.

5

Familial renal glycosuria as a genetic model of long-term SGLT2 inhibition: potential implications for calcium phosphate metabolism and bone health.

Rroji M, Kasa M, Spahia N, Spasovski G, Müller RU. Rroji M, et al. Among authors: spahia n. J Nephrol. 2024 Dec 21. doi: 10.1007/s40620-024-02164-7. Online ahead of print. J Nephrol. 2024. PMID: 39707129 No abstract available.

6

Beyond the itch: chronic kidney disease-associated pruritus, a multimodal approach, and the role of difelikefalin.

Spahia N, Rroji M, Mumajesi S, Cafi E, Buzi M. Spahia N, et al. Arch Dermatol Res. 2024 Dec 14;317(1):120. doi: 10.1007/s00403-024-03640-7. Arch Dermatol Res. 2024. PMID: 39673561 No abstract available.

7

A New Hope on the Horizon for Kidney and Cardiovascular Protection with SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Mineralocorticoid Receptor Antagonists in Type 2 Diabetic and Chronic Kidney Disease Patients.

Spasovski G, Rroji M, Hristov G, Bushljetikj O, Spahia N, Rambabova Bushletikj I. Spasovski G, et al. Among authors: spahia n. Metab Syndr Relat Disord. 2024 Apr;22(3):170-178. doi: 10.1089/met.2023.0227. Epub 2024 Feb 21. Metab Syndr Relat Disord. 2024. PMID: 38386800

8

Sodium and water dynamics in the progression of chronic kidney disease: mechanisms and clinical significance.

Spahia N, Rroji M, Idrizi A, Spasovski G, Barbullushi M. Spahia N, et al. Int Urol Nephrol. 2024 Jun;56(6):1953-1963. doi: 10.1007/s11255-023-03903-8. Epub 2024 Jan 10. Int Urol Nephrol. 2024. PMID: 38200365 Review.

9

The Role of Protein Restriction in the Progression of Chronic Kidney Disease.

Spahia N, Rroji M, Barbullushi M, Spasovski G. Spahia N, et al. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2023 Jul 15;44(2):53-63. doi: 10.2478/prilozi-2023-0025. Print 2023 Jul 1. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2023. PMID: 37453111 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters